Adaptimmune Therapeutics PLC (ADAP)
1.195
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.195
0.00 (0.00%)
After-Hours: 18:07
Adaptimmune Therapeutics Max Drawdown (5Y): 96.57% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.57% |
March 31, 2024 | 96.57% |
February 29, 2024 | 96.57% |
January 31, 2024 | 96.57% |
December 31, 2023 | 96.57% |
November 30, 2023 | 96.57% |
October 31, 2023 | 96.57% |
September 30, 2023 | 96.57% |
August 31, 2023 | 96.57% |
July 31, 2023 | 96.57% |
June 30, 2023 | 96.57% |
May 31, 2023 | 96.57% |
April 30, 2023 | 96.57% |
March 31, 2023 | 96.57% |
February 28, 2023 | 96.57% |
January 31, 2023 | 96.57% |
December 31, 2022 | 96.57% |
November 30, 2022 | 96.57% |
October 31, 2022 | 96.57% |
September 30, 2022 | 96.57% |
August 31, 2022 | 96.57% |
July 31, 2022 | 96.57% |
June 30, 2022 | 96.57% |
May 31, 2022 | 96.57% |
April 30, 2022 | 96.57% |
Date | Value |
---|---|
March 31, 2022 | 96.57% |
February 28, 2022 | 96.57% |
January 31, 2022 | 96.57% |
December 31, 2021 | 96.57% |
November 30, 2021 | 96.57% |
October 31, 2021 | 96.57% |
September 30, 2021 | 96.57% |
August 31, 2021 | 96.57% |
July 31, 2021 | 96.57% |
June 30, 2021 | 96.57% |
May 31, 2021 | 96.57% |
April 30, 2021 | 96.57% |
March 31, 2021 | 96.57% |
February 28, 2021 | 96.57% |
January 31, 2021 | 96.57% |
December 31, 2020 | 96.57% |
November 30, 2020 | 96.57% |
October 31, 2020 | 96.57% |
September 30, 2020 | 96.57% |
August 31, 2020 | 96.57% |
July 31, 2020 | 96.57% |
June 30, 2020 | 96.57% |
May 31, 2020 | 96.57% |
April 30, 2020 | 96.57% |
March 31, 2020 | 96.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.71%
Minimum
May 2019
96.57%
Maximum
Nov 2019
95.87%
Average
96.57%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Biodexa Pharmaceuticals Plc | 100.00% |
NuCana PLC | 98.68% |
Autolus Therapeutics PLC | 96.58% |
Mereo BioPharma Group PLC | 94.92% |
TC BioPharm (Holdings) PLC | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -53.61 |
Beta (5Y) | 2.442 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 159.4% |
Historical Sharpe Ratio (5Y) | -0.1656 |
Historical Sortino (5Y) | -0.5785 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.72% |